Cansino Biologics Inc(688185) : special statement on the occupation of funds by controlling shareholders, actual controllers and other related parties

Cansino Biologics Inc(688185) Jinyu Bio-Technology Co.Ltd(600201) company

Special instructions on the occupation of funds by controlling shareholders, actual controllers and other related parties

Year ended December 31, 2021

Cansino Biologics Inc(688185) Jinyu Bio-Technology Co.Ltd(600201) company’s occupation of non operating funds and other related capital transactions in 2021

Monetary unit: RMB 10000

Occupiers and listed companies accounted for 2021 in 2021 in 2021 in 2021

Name of the occupier of non operating funds: the accounting department calculated by the listed company uses the profits of the accumulated funds at the beginning of the year to repay the accumulated funds at the end of the year to account for the amount of funds occupied by the related items with the nature of occupation (excluding interest (if any). The amount is caused by the use of funds

Tie balance (interest)

Current major shareholders and their subsidiaries are not applicable, not applicable, not applicable – not applicable, not applicable to enterprises

Subtotal / //

Former major shareholders and their subsidiaries are not applicable, not applicable, not applicable – not applicable, not applicable to enterprises

Subtotal / //

Total / //

Between the counterparty and the listed company from 2021 to 2021 to 2021

Name of other related capital transaction parties listed companies calculate the accumulated profits and repayments of funds from the accounting department at the beginning of the year. The accumulated amount of funds (excluding interest (if any) at the end of the period often forms the relationship of transaction nature. The amount of funds from transactions is the reason

Balance (interest)

Major shareholders and their affiliated enterprises not applicable not applicable not applicable – not applicable not applicable

trade

Other receivables of Cansino Biologics Inc(688185) subsidiary of Shanghai Shangyao pharmaceutical – 1350000 49.611354961 – capital split borrowing and lending of Wu Pharmaceutical Co., Ltd., a subsidiary of a non operating listed company

Other receivables of Cansino Biologics Inc(688185) (Shanghai) shengsun company and its subsidiaries – 500.00-500.00 prepaid current account for non operating property R & D Co., Ltd

Related natural person not applicable not applicable not applicable – not applicable not applicable

Other related parties and their attachments not applicable not applicable not applicable – not applicable not applicable

Affiliated enterprise

Total / – 1400000 49.611354961 500.00 //

- Advertisment -